FonarFONR
FONR
About: Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue.
Employees: 520
0
Funds holding %
of 7,312 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
18% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 11
0.67% less ownership
Funds ownership: 49.66% [Q4 2024] → 48.98% (-0.67%) [Q1 2025]
10% less capital invested
Capital invested by funds: $47.1M [Q4 2024] → $42.5M (-$4.59M) [Q1 2025]
12% less funds holding
Funds holding: 52 [Q4 2024] → 46 (-6) [Q1 2025]
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 6
Research analyst outlook
We haven’t received any recent analyst ratings for FONR.
Financial journalist opinion
Neutral
Newsfile Corp
1 day ago
FONAR Board of Directors Announces Receipt of Non-Binding "Take Private" Proposal
Melville, New York--(Newsfile Corp. - July 9, 2025) - FONAR Corporation (NASDAQ: FONR) ("FONAR"), The Inventor of MR Scanning™, today announced that its board of directors (the "Board") received a preliminary, non-binding proposal letter, dated July 7, 2025 from a Proposed Acquisition Group led by Timothy Damadian and consisting of certain members of the management team and Board of Directors of FONAR Corporation and third parties, to acquire all of the outstanding capital stock of FONAR not currently owned by the Proposed Acquisition Group, at a price per share anticipated to be "at a premium of no less than 10% to the average closing market price of FONAR's common stock for the 90 trading days immediately preceding July 1, 2025". The letter states that the Proposed Acquisition Group currently beneficially owns approximately 5.01% of the outstanding FONAR Stock.
Neutral
Newsfile Corp
1 week ago
FONAR Board of Directors Appoints Independent Director
Melville, New York--(Newsfile Corp. - July 2, 2025) - FONAR Corporation (NASDAQ: FONR), The Inventor of MR Scanning, today announced that on July 2, 2025, its board of directors appointed Mr. Robert M. Carrino as an independent director of the Company's board of directors.
Positive
Zacks Investment Research
1 month ago
FONR Stock Rises Following Q3 Earnings on Higher Net Income
FONAR Corporation's Q3 fiscal 2025 results show higher net income and revenue growth, driven by record MRI scan volumes and strong performance of its HMCA unit.
Neutral
Newsfile Corp
1 month ago
Fonar Announces Fiscal 2025 Financial Results for 3rd Quarter and Nine-Month Period
Net Income increased 25% to $3.1 million for the quarter ended March 31, 2025 as compared to the quarter ended March 31, 2024. Income from Operations for the quarter ended March 31, 2025 decreased 2% to $3.7 million as compared to the quarter ended March 31, 2024.
Negative
Zacks Investment Research
4 months ago
FONR Stock Declines After Q2 Earnings, Revenue and Net Income Fall
FONAR's second-quarter fiscal 2025 revenues and net income decline. Higher costs and lower scan volumes weigh on results.
Neutral
Newsfile Corp
4 months ago
Fonar Announces Six Month and 2nd Quarter Financial Results for Fiscal 2025
MRI scan volume at HMCA managed sites increased 7% to 79,207 scans during the six-month period ended December 31, 2024, versus 73,776 scans for the six-month period ended December 31, 2023. MRI scan volume at HMCA owned sites decreased 4% to 26,961 scans during the six-month period ended December 31, 2024, versus 28,214 scans for the six-month period ended December 31, 2023.
Positive
Seeking Alpha
7 months ago
FONAR: Assets Remain Too Cheap To Pass Up
Despite recent underperformance, FONAR remains a value play with minimal debt, positive profitability, and attractive valuation multiples, particularly a P/B ratio of 0.61. Q1-Fiscal 2025 earnings showed a decline, but FONAR's book value continues to grow, driven by strategic investments in high-field MRI scanners and new locations. Risks include market punishment for near-term growth rates and low trading volume, but downside risk is limited due to strong financials and shareholder-friendly trends.
Neutral
Zacks Investment Research
7 months ago
FONR Stock Gains Despite Q1 Earnings Dip and Rising Expenses
FONAR's fiscal first-quarter earnings reveals a decline in revenues and income, driven by decreased patient fees and rising costs, while MRI scan volume sees modest growth.
Neutral
Newsfile Corp
7 months ago
Fonar Announces Financial Results for the 1st Quarter of Fiscal 2025
Total MRI scan volume at the HMCA-managed sites increased 5% to 53,054 scans for the quarter ending September 30, 2024 versus the corresponding quarter one year earlier. Cash and cash equivalents decreased 4% to $54.2 million at September 30, 2024 as compared to the fiscal year-ended June 30, 2024.
Neutral
Zacks Investment Research
9 months ago
FONR's Stock Down Despite Earnings, Revenues Uptick in Fiscal 2024
Strength in FONAR's HMCA segment's revenues drives its top line in fiscal 2024.
Charts implemented using Lightweight Charts™